Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancer
Thursday, June 17, 2010 - 09:52
in Health & Medicine
Biologics-naďve Juvenile Idiopathic Arthritis (JIA) patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an increased frequency of cancer in those receiving the biologic etanercept, however, results were deemed not statistically significant by researchers.